138 related articles for article (PubMed ID: 10544034)
1. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
[TBL] [Abstract][Full Text] [Related]
2. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
3. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
Shan L; Wang L; Yin J; Zhong P; Zhong J
J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599
[TBL] [Abstract][Full Text] [Related]
4. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
7. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
8. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
10. Efficient method for expressing transgenes in nonhuman primate embryos using a stable episomal vector.
Wolfgang MJ; Marshall VS; Eisele SG; Schotzko ML; Thomson JA; Golos TG
Mol Reprod Dev; 2002 May; 62(1):69-73. PubMed ID: 11933162
[TBL] [Abstract][Full Text] [Related]
11. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
[TBL] [Abstract][Full Text] [Related]
13. Long-term gene expression from autonomously replicating vectors in mammalian cells.
Wohlgemuth JG; Kang SH; Bulboaca GH; Nawotka KA; Calos MP
Gene Ther; 1996 Jun; 3(6):503-12. PubMed ID: 8789800
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
[TBL] [Abstract][Full Text] [Related]
15. Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion.
Min KA; Lee SK; Kim CK
Biomaterials; 2005 Mar; 26(9):1063-70. PubMed ID: 15369695
[TBL] [Abstract][Full Text] [Related]
16. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells.
Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O
J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
18. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.
Sun TQ; Livanos E; Vos JM
Gene Ther; 1996 Dec; 3(12):1081-8. PubMed ID: 8986434
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
20. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]